Captrust Financial Advisors Optimize Rx Corp Transaction History

Captrust Financial Advisors

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$7.06 - $14.49 $1,023 - $2,101	-145 Reduced 0.63%	22,723 $325,000
Q3 2023 Nov 14, 2023	BUY	$7.43 - $14.96 $169,909 - $342,105	22,868 New	22,868 $177,000
Q2 2022 Aug 16, 2022	BUY	$21.94 - $40.49 $20,140 - $37,169	918 Added 248.78%	1,287 $35,000
Q1 2022 May 16, 2022	BUY	$35.27 - $62.91 $1,093 - $1,950	31 Added 9.17%	369 $14,000
Q4 2021 Feb 14, 2022	BUY	$53.57 - $98.0 $1,017 - $1,862	19 Added 5.96%	338 $21,000
Q2 2021 Aug 16, 2021	BUY	$42.76 - $63.33 $812 - $1,203	19 Added 6.33%	319 $20,000
Q4 2020 Feb 16, 2021	BUY	$19.04 - $33.1 $5,712 - $9,930	300 New	300 $9,000

13M

800

18.1K

Ticker OPRX
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 18,023,100
Market Cap $102M
Description
OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patien...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.